BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2247023)

  • 1. Erythrocyte individual phospholipids and erythrocyte membrane fluidity in subjects with vascular atherosclerotic disease with and without diabetes mellitus of type 2.
    Caimi G; Serra A; Catania A; D'Asaro S; Montana M; Lo Presti R; Sarno A
    Microcirc Endothelium Lymphatics; 1990; 6(2-3):149-57. PubMed ID: 2247023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavior of the polymorphonuclear leukocyte membrane fluidity and cystolic Ca2+ content in vascular atherosclerotic disease with and without non-insulin-dependent diabetes mellitus.
    Caimi G; Canino B; Montana M; Ferrara F; Ventimiglia G; Meli F; Romano A; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(6):429-36. PubMed ID: 9502527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total red cell Ca2+ content and rheological determinants in a group of subjects with vascular atherosclerotic disease.
    Caimi G; Lo Presti R; Serra A; Grifò G; Romano A; Catania A; Sarno A
    Microcirc Endothelium Lymphatics; 1990 Feb; 6(1):35-43. PubMed ID: 2355903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheological determinants and red cell lipidic pattern in essential obesity, in obese subjects with non-insulin-dependent diabetes mellitus (NIDDM) and in obese subjects with impaired glucose tolerance (IGT).
    Caimi G; Lo Presti R; Serra A; Catania A; D'Asaro S; Verga S; Buscemi S; Sarno A
    Microcirc Endothelium Lymphatics; 1991; 7(4-6):293-304. PubMed ID: 1815108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet membrane fluidity in non-insulin-dependent diabetes mellitus (NIDDM) subjects, in subjects with vascular atherosclerotic disease (VAD) and in VAD subjects with NIDDM.
    Caimi G; Canino B; Montana M; Catania A; Lo Presti R
    Thromb Haemost; 1999 Jul; 82(1):149. PubMed ID: 10456470
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrocyte membrane fluidity and red cell cytosolic Ca2+ content during incubation, in normals and in subjects with vascular atherosclerotic disease and non-insulin-dependent diabetes mellitus.
    Caimi G; Canino B; Montana M; Lo Presti R
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):195-7. PubMed ID: 9699042
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in different clinical conditions.
    Caimi G; Canino B; Montana M; Ventimiglia G; Catania A; Lo Presti R
    Clin Hemorheol Microcirc; 1997; 17(3):217-23. PubMed ID: 9356786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell membrane dynamic properties and erythrocyte metabolic parameters in essential hypertension: preliminary report.
    Caimi G; Contorno A; Serra A; Lo Presti R; Grifo G; D'Asaro S; Catania A; Sarno A; Cerasola G
    Microcirc Endothelium Lymphatics; 1991; 7(4-6):245-55. PubMed ID: 1815106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according to its extent.
    Lo Presti R; Tozzi Ciancarelli MG; Canino B; Carollo C; Lucido D; Amodeo G; Romano A; Caimi G
    Clin Hemorheol Microcirc; 2006; 35(1-2):199-201. PubMed ID: 16899927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total red cell calcium content, cytosolic red cell free calcium and erythrocyte membrane dynamic properties in diabetes mellitus.
    Caimi G; Serra A; Lo Presti R; Grifo G; Romano A; Galluzzo A; Sarno A
    Microcirc Endothelium Lymphatics; 1991; 7(4-6):257-66. PubMed ID: 1815107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte aggregation and erythrocyte membrane properties in type 2 diabetes mellitus and in vascular atherosclerotic disease.
    Caimi G; Canino B; Romano A; Catania A; Lo Presti R
    Thromb Haemost; 2000 Mar; 83(3):516-7. PubMed ID: 10744168
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphonuclear leukocyte: rheology, metabolism and integrin pattern in vascular atherosclerotic disease and in type 2 diabetes mellitus.
    Caimi G; Lo Presti R; Montana M; Carollo C; Amodeo G; Romano A; Canino B
    Clin Hemorheol Microcirc; 2004; 30(3-4):229-35. PubMed ID: 15258348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
    Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
    Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane.
    Martínez M; Vayá A; Server R; Gilsanz A; Aznar J
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):253-8. PubMed ID: 9741665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet membrane fluidity and platelet membrane lipid pattern in essential hypertension.
    Caimi G; Lo Presti R; Montana M; Contorno A; Canino B; Catania A; Sarno A; Cerasola G
    Am J Hypertens; 1995 Jan; 8(1):82-6. PubMed ID: 7734103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte flow properties, polymorphonuclear membrane fluidity, and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease with and without noninsulin-dependent diabetes mellitus.
    Caimi G; Canino B; Ferrara F; Montana M; Meli F; Catania A; Lo presti R
    Angiology; 1996 Aug; 47(8):757-63. PubMed ID: 8712478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythrocyte phospholipids and membrane fluidity in a group of atherosclerotic vascular disease patients. Preliminary results].
    Caimi G; Catania A; Serra A; D'Asaro S; Romano A; Lo Presti R; Sarno A
    Ric Clin Lab; 1989; 19 Suppl 1():137-9. PubMed ID: 2629074
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal thiol group modulation of sodium-lithium countertransport and membrane fluidity is associated with a disturbed relationship between serum triacylglycerols and membrane function in type II diabetes.
    Senior PA; Thomas TH; Marshall SM
    Clin Sci (Lond); 2000 Jun; 98(6):673-80. PubMed ID: 10814604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte flow properties, polymorphonuclear membrane fluidity and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease.
    Caimi G; Lo Presti R; Canino B; Ferrara F; Montana M; Ventimiglia G; Catania A; Cospite M; Sarno A
    Artery; 1997; 22(6):328-35. PubMed ID: 9921407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron spin resonance study of the erythrocyte membrane fluidity changes in diabetes.
    Preoteasa EA; Ionescu-Tîrgovişte C; Grecu VV; Georgescu R
    Rom J Intern Med; 1993; 31(4):271-82. PubMed ID: 8148779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.